Dissolution Testing Based On Scientific Justification Recommended By GPhA, PhRMA
This article was originally published in The Pink Sheet Daily
Executive Summary
Proposals from both the generic and innovator trade groups will be discussed at the Oct. 25-26 meeting of FDA’s Advisory Committee for Pharmaceutical Science.